share_log

Tonix Pharmaceuticals Q2 EPS $(1.22) Up From $(2.24) YoY

Benzinga Real-time News ·  Aug 8, 2022 07:54

Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(1.22) per share. This is a 45.54 percent increase over losses of $(2.24) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment